FDA to Review First of 3 New Weight Loss Drugs

Published July 15, 2010

FDA to review first of 3 new weight loss drugs
Dieters, doctors and investors get their first extensive look at the first of a trio of new weight loss drugs this week. The hope is that the new drugs can succeed where many others have failed: delivering significant weight loss without risky side effects. Weight loss – Health – Food and Drug Administration – Shopping – Adverse effect
Read more on MSNBC

Vivus shares fall ahead of review for obesity drug
Shares of drug maker Vivus fell Monday ahead of a public meeting where federal health advisers will scrutinize the company’s highly anticipated weight loss drug.
Read more on AP via Yahoo! Finance

Will FDA Approve 3 New Diet Pills?
New Prescription Drugs to Curb Big Appetites, But Side Effects an Issue
Read more on CBS News